Added to YB: 2023-09-26
Pitch date: 2023-09-26
MXCT [bullish]
MaxCyte, Inc.
-39.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
Market Cap
$168.5M
Pitch Price
$2.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.87
P/E
-3.67
EV/Sales
2.35
Sector
Life Sciences Tools and Services
Category
N/A
Show full summary:
MAXCYTE INC (MXCT) MXCT
A summary for this pitch has not been created yet.
Read full article (0 min)